Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 68K
2: EX-99.1 Miscellaneous Exhibit HTML 35K
3: EX-99.2 Miscellaneous Exhibit HTML 41K
8: R1 Cover HTML 114K
10: XML IDEA XML File -- Filing Summary XML 12K
13: XML XBRL Instance -- ibm-20240424_htm XML 83K
9: EXCEL IDEA Workbook of Financial Report Info XLSX 10K
5: EX-101.DEF XBRL Definitions -- ibm-20240424_def XML 71K
6: EX-101.LAB XBRL Labels -- ibm-20240424_lab XML 158K
7: EX-101.PRE XBRL Presentations -- ibm-20240424_pre XML 74K
4: EX-101.SCH XBRL Schema -- ibm-20240424 XSD 27K
11: JSON XBRL Instance as JSON Data -- MetaLinks 23± 30K
12: ZIP XBRL Zipped Folder -- 0000051143-24-000021-xbrl Zip 54K
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading symbol(s)
Name of each exchange on which registered
iiCapital stock, par value $.20 per share/
iiIBM/
iNew
York Stock Exchange
NYSE Chicago
i1.125% Notes due 2024
iIBM 24A
iNew
York Stock Exchange
i2.875% Notes due 2025
iIBM 25A
iNew York
Stock Exchange
i0.950% Notes due 2025
iIBM 25B
iNew York Stock
Exchange
i0.875% Notes due 2025
iIBM 25C
iNew York Stock Exchange
i0.300%
Notes due 2026
iIBM 26B
iNew York Stock Exchange
i1.250% Notes
due 2027
iIBM 27B
iNew York Stock Exchange
i3.375% Notes due
2027
iIBM 27F
iNew York Stock Exchange
i0.300% Notes due 2028
iIBM
28B
iNew York Stock Exchange
i1.750% Notes due 2028
iIBM 28A
iNew
York Stock Exchange
i1.500% Notes due 2029
iIBM 29
iNew York
Stock Exchange
i0.875% Notes due 2030
iIBM 30A
iNew York Stock
Exchange
i1.750% Notes due 2031
iIBM 31
iNew York Stock Exchange
i3.625%
Notes due 2031
iIBM 31B
iNew York Stock Exchange
i0.650% Notes
due 2032
iIBM 32A
iNew York Stock Exchange
i1.250% Notes due
2034
iIBM 34
iNew York Stock Exchange
i3.750% Notes due 2035
iIBM
35
iNew York Stock Exchange
i4.875% Notes due 2038
iIBM 38
iNew
York Stock Exchange
i1.200% Notes due 2040
iIBM 40
iNew York
Stock Exchange
i4.000% Notes due 2043
iIBM 43
iNew York Stock
Exchange
i7.00% Debentures due 2025
iIBM 25
iNew York Stock
Exchange
i6.22% Debentures due 2027
iIBM 27
iNew York Stock
Exchange
i6.50% Debentures due 2028
iIBM 28
iNew York Stock
Exchange
i5.875% Debentures due 2032
iIBM 32D
iNew York Stock
Exchange
i7.00% Debentures due 2045
iIBM 45
iNew York Stock
Exchange
i7.125% Debentures due 2096
iIBM 96
iNew York Stock
Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
Exhibit 99.1 of this Form 8-K contains the prepared remarks for IBM's Chairman and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's first-quarter 2024
earnings presentation to investors on April 24, 2024.
The slides for IBM's Chairman and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's first-quarter 2024 earnings presentation on April 24, 2024, are Exhibit 99.2 to this Form 8-K.
Reconciliations of non-GAAP financial measures discussed in the earnings presentation to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in Exhibit 99.2 to this Form 8-K.
The information in this Item 7.01, including the corresponding Exhibits 99.1 and 99.2, is
being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are being furnished as part of this report:
The following exhibit is being filed as part of this report:
Exhibit No.
Description of Exhibit
104
Cover
Page Interactive Data File (embedded within the Inline XBRL Document)
IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.